Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance Published on April 6, 2021Business Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. Food and Drug Administration 510 (k) clearance for its Philips SmartCT application software. More